A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

Clinical trial NCT07505771 · RECRUITING

Trial details

NCT number: NCT07505771
Sponsor: Immunome, Inc.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Solid Malignancies

Start date: 2026-06-19
Primary completion: 2029-12-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.